Clinical trial
Biological Therapy Following Chemotherapy and Peripheral Stem Cell…
NCT00003408 · Cancer Treatment Centers of America, Other · Completed
Key facts
| NCT number | NCT00003408 |
|---|---|
| Title | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer |
| Official title | Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation |
| Lead sponsor | Cancer Treatment Centers of America, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer and 2 more |
| Intervention type | Biological |
| Interventions | aldesleukin, recombinant interferon alfa, sargramostim |
| Enrollment | 40 |
| Start date | Apr 1, 1998 |
| Completion | Mar 1, 2000 |
| First posted | May 23, 2003 |
| Last update posted | Mar 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: